Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Future Microbiology

• Publication date

  2018-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/fmb-2018-0186PMID 30311780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection

  2018cited by this paper
• Are leprosy case numbers reliable?

  2018cited by this paper
• Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties

  2017cited by this paper
• Ten failings in global neglected tropical diseases control

  2017cited by this paper
• Introducing leprosy post-exposure prophylaxis into the health systems of India, Nepal and Indonesia: a case study

  2017cited by this paper
• Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial

  2017cited by this paper
• Addition of Mycobacterium indicus pranii vaccine as an immunotherapeutic to standard chemotherapy in borderline leprosy: a double‐blind study to assess clinical improvement (preliminary report)

  2017cited by this paper
• Global leprosy update, 2016: accelerating reduction of disease burden.

  2017cited by this paper
• Global leprosy strategy 2016–2020: Issues and concerns

  2017cited by this paper
• Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin

  2016cited by this paper
• Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy

  2016cited by this paper
• Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.

  2015cited by this paper
• The Missing Millions: A Threat to the Elimination of Leprosy

  2015cited by this paper
• Impact of PGL-I Seropositivity on the Protective Effect of BCG Vaccination among Leprosy Contacts: A Cohort Study

  2012cited by this paper
• Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy.

  2012cited by this paper
• Effectiveness of BCG vaccination among leprosy contacts: a cohort study.

  2008cited by this paper
• BCG Revaccination Does Not Protect Against Leprosy in the Brazilian Amazon: A Cluster Randomised Trial

  2008cited by this paper
• The role of BCG in prevention of leprosy: a meta-analysis.

  2006cited by this paper

• Leprosy reactions: New knowledge on pathophysiology, diagnosis, treatment and prevention.

  2024cites this paper
• Increscent Journey of Anti-Leprosy Drug Development

  2023cites this paper
• The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis

  2020cites this paper
• Leprosy vaccines – A voyage unfinished

  2020cites this paper
• RRTM_A_190300 97..117

  2020cites this paper